Detalhe da pesquisa
1.
Feasibility and efficacy of CD19-targeted CAR T cells with concurrent ibrutinib for CLL after ibrutinib failure.
Blood
; 135(19): 1650-1660, 2020 05 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32076701
2.
Incidence and socioeconomic factors in older adults with acute myeloid leukaemia: Real-world outcomes from a population-based cohort.
Eur J Haematol
; 108(5): 437-445, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35122325
3.
High rate of durable complete remission in follicular lymphoma after CD19 CAR-T cell immunotherapy.
Blood
; 134(7): 636-640, 2019 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31648294
4.
Factors associated with durable EFS in adult B-cell ALL patients achieving MRD-negative CR after CD19 CAR T-cell therapy.
Blood
; 133(15): 1652-1663, 2019 04 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30728140
5.
The response to lymphodepletion impacts PFS in patients with aggressive non-Hodgkin lymphoma treated with CD19 CAR T cells.
Blood
; 133(17): 1876-1887, 2019 04 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-30782611
6.
Infectious complications of CD19-targeted chimeric antigen receptor-modified T-cell immunotherapy.
Blood
; 131(1): 121-130, 2018 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29038338
7.
Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor-modified T-cell therapy.
Blood
; 130(21): 2295-2306, 2017 11 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-28924019
8.
Cytokine release syndrome and neurotoxicity after CD19 chimeric antigen receptor-modified (CAR-) T cell therapy.
Br J Haematol
; 183(3): 364-374, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30407609
9.
Innovations en immunothérapie anticancéreuse: thérapie par lymphocytes T porteurs de récepteurs antigéniques chimériques (cellules CAR-T).
CMAJ
; 193(42): E1639-E1642, 2021 10 25.
Artigo
em Francês
| MEDLINE | ID: mdl-34697102
10.
Innovations in cancer immunotherapy: chimeric antigen receptor T-cell therapy (CAR-T).
CMAJ
; 193(33): E1300-E1302, 2021 08 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34426446
11.
Discovery and preclinical development of a therapeutically active nanobody-based chimeric antigen receptor targeting human CD22.
Mol Ther Oncol
; 32(1): 200775, 2024 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38596311
12.
A systematic review and meta-analysis of CD22 CAR T-cells alone or in combination with CD19 CAR T-cells.
Front Immunol
; 14: 1178403, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37180149
13.
CLIC-01: Manufacture and distribution of non-cryopreserved CAR-T cells for patients with CD19 positive hematologic malignancies.
Front Immunol
; 13: 1074740, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36601119
14.
Efficacy and safety of CD22 chimeric antigen receptor (CAR) T cell therapy in patients with B cell malignancies: a protocol for a systematic review and meta-analysis.
Syst Rev
; 10(1): 35, 2021 01 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-33478595
15.
Weathering the COVID-19 storm: Lessons from hematologic cytokine syndromes.
Blood Rev
; 45: 100707, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32425294
16.
A Rapid and Sensitive Nucleic Acid Amplification Technique for Mycoplasma Screening of Cell Therapy Products.
Mol Ther Methods Clin Dev
; 17: 393-399, 2020 Jun 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32128343
17.
Durable preservation of antiviral antibodies after CD19-directed chimeric antigen receptor T-cell immunotherapy.
Blood Adv
; 3(22): 3590-3601, 2019 11 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-31743392
18.
Safety of allogeneic hematopoietic cell transplant in adults after CD19-targeted CAR T-cell therapy.
Blood Adv
; 3(20): 3062-3069, 2019 10 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-31648329
19.
Chimeric Antigen Receptor (CAR) T Cells: Lessons Learned from Targeting of CD19 in B-Cell Malignancies.
Drugs
; 77(3): 237-245, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28110394
20.
Durable Molecular Remissions in Chronic Lymphocytic Leukemia Treated With CD19-Specific Chimeric Antigen Receptor-Modified T Cells After Failure of Ibrutinib.
J Clin Oncol
; 35(26): 3010-3020, 2017 Sep 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28715249